Analgesic Activity of Hexaazaisowurtzitane Derivatives


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,03, 11,05, 9] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals.

About the authors

S. G. Krylova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Author for correspondence.
Email: krylova5935@gmail.com
Russian Federation, Tomsk

T. N. Povet’eva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

E. P. Zueva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

N. I. Suslov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

E. N. Amosova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

T. G. Razina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

K. A. Lopatina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

O. Yu. Rybalkina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

Yu. V. Nesterova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

O. G. Afanas’eva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

E. A. Kiseleva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk

S. V. Sysolyatin

Institute of Problems of Chemical and Energetic Technologies, Siberian Division of the Russian Academy of Sciences

Email: krylova5935@gmail.com
Russian Federation, Biysk

D. A. Kulagina

Institute of Problems of Chemical and Energetic Technologies, Siberian Division of the Russian Academy of Sciences

Email: krylova5935@gmail.com
Russian Federation, Biysk

V. V. Zhdanov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
Russian Federation, Tomsk


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies